The China spinal fusion market is expected to grow through 2025, based on a Future Market Insights report, according to Medgadget.
Here are six points:
1. China has experienced an increase in spinal fusion surgeries due to better reimbursements and more patients opting for minimally invasive surgery.
2. An aging population and increasing incomes are driving more people with back issues to undergo spinal fusion surgery.
3. New technologies, such as improved implant materials, encourage more people to seek spinal fusion surgery.
4. The Chinese government and economic growth have facilitated spinal treatment for patients in rural areas by opening doors for better access to healthcare.
5. The market faces some obstacles in high surgery costs and alternative options, such as Intradiscal Electrothermal Annuloplasty.
6. Trauson, DePuy Synthes, Biomet, Medtronic, NuVasive, Stryker, Zimmer, Orthofix International, B. Braun Aesculap and Weigao Orthopaedic Device lead the market.